Q29. Differentiate Upper Motor Neuron (UMN) and Lower Motor Neuron (LMN) Lesions with Appropriate Examples (15 Marks) Q30. Describe Bruce Protocol (15 Marks)

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
I now have all the information needed to write comprehensive answers for both questions. Let me compile the full responses.

Q29. Differentiate Upper Motor Neuron (UMN) and Lower Motor Neuron (LMN) Lesions with Appropriate Examples (15 Marks)


Introduction

The motor system consists of two major neuronal groups that work in series: upper motor neurons (UMN) and lower motor neurons (LMN). Understanding their differences is fundamental to clinical neurological localization - knowing where a lesion is located based on the pattern of signs observed.

Anatomical Basis

Upper Motor Neurons (UMN)

UMNs originate in the cerebral cortex (primary motor cortex, pre-motor cortex) and project downward via the corticospinal tract (for spinal movements) and the corticobulbar tract (for cranial nerve-innervated muscles). They synapse on lower motor neurons in the anterior horn of the spinal cord or in cranial nerve nuclei of the brainstem. UMNs are entirely within the central nervous system (CNS).

Lower Motor Neurons (LMN)

LMNs are located in the anterior horn of the spinal cord (or cranial nerve motor nuclei in the brainstem). They project via peripheral nerves directly to skeletal muscle. They are the "final common pathway." LMNs include the anterior horn cell, nerve root, plexus, and peripheral nerve - all components of the peripheral nervous system (PNS).

Key Differentiating Features

Sign / FeatureUMN LesionLMN Lesion
WeaknessYes (paresis/paralysis)Yes (paresis/paralysis)
Muscle ToneIncreased (spasticity)*Decreased (flaccidity)
Deep Tendon ReflexesIncreased (hyperreflexia)*Decreased or absent (hyporeflexia/areflexia)
Muscle AtrophyAbsent (or mild disuse atrophy)Prominent and early
FasciculationsAbsentPresent
Babinski SignPositive (extensor plantar response)Absent (flexor or no response)
Hoffmann's SignMay be positiveAbsent
Pattern of WeaknessExtensors + abductors of UL; Flexors of LL (proximal > distal)Any muscle group in distribution of nerve/root (distal > proximal)
ClonusMay be presentAbsent
DistributionOften hemiplegic or paraplegic (broad distribution)Focal, follows nerve or root distribution
Note: In acute UMN lesions (e.g., spinal shock), reflexes and tone are initially decreased (flaccid paralysis). Over hours to weeks, the classic picture of hyperreflexia and spasticity emerges.

Pathophysiology Explained

Why is UMN tone/reflexes increased?

The corticospinal tract normally travels alongside descending inhibitory pathways that suppress lower motor neuron excitability. When these are damaged, lower motor neurons in the anterior horn become disinhibited, leading to increased excitability - manifesting as brisk reflexes and increased tone (spasticity). This is why the Babinski sign, Hoffmann's sign, and clonus appear.

Why does LMN produce atrophy and fasciculations?

When the LMN is damaged, muscles lose their innervation entirely. The muscle undergoes denervation atrophy - loss of trophic support from the nerve. Fasciculations are caused by spontaneous, irregular firing of a whole motor unit (a single anterior horn cell and all the muscle fibers it innervates) due to denervation hypersensitivity and spontaneous activity.

Why no Babinski in LMN?

The Babinski (extensor plantar) reflex depends on an intact UMN-to-LMN arc. If the LMN (the efferent arc itself) is destroyed, the reflex response cannot be executed.

Distribution of Weakness

UMN weakness characteristically affects:
  • Upper limb: Extensors and abductors (arm hangs in flexion - "pyramidal pattern")
  • Lower limb: Flexors (leg extends - patient has a circumducting gait, dragging the stiff leg)
  • Cortical UMN lesions may spare the face on one side (due to bilateral cortical representation)
LMN weakness follows precise anatomical territories:
  • A damaged single peripheral nerve affects only its specific muscle group
  • A root lesion (radiculopathy) affects a myotomal distribution
  • Anterior horn cell disease may affect multiple levels

Clinical Examples

UMN Lesion Examples

  1. Stroke (Cerebral Infarction/Hemorrhage)
    • Lesion in the internal capsule or motor cortex
    • Result: Contralateral hemiplegia with spasticity, hyperreflexia, positive Babinski
    • Face, arm, and leg affected (if internal capsule) - "middle cerebral artery territory"
  2. Spinal Cord Injury (Cervical Myelopathy / Transection)
    • Lesion at or above C4: quadriplegia; C5-T1: paraplegia with arms affected
    • Initially flaccid (spinal shock), followed by spastic paraplegia
    • Positive Babinski, clonus, hyperreflexia below the lesion
    • Loss of voluntary bladder/bowel control
  3. Multiple Sclerosis (MS)
    • Demyelination of corticospinal tracts causes spastic paraparesis
    • Lhermitte's sign (electric shock down spine on neck flexion) is characteristic
  4. Amyotrophic Lateral Sclerosis (ALS) - UMN component
    • Both UMN and LMN are involved
    • UMN signs: spasticity, hyperreflexia, positive Babinski
  5. Cerebral Palsy
    • Perinatal UMN damage: spastic hemiplegia/diplegia with scissors gait

LMN Lesion Examples

  1. Poliomyelitis
    • Destruction of anterior horn cells (LMN cell body)
    • Asymmetric flaccid paralysis, severe atrophy, areflexia, fasciculations
    • No sensory loss (pure motor)
  2. Peripheral Neuropathy (e.g., Diabetic Neuropathy, Guillain-Barre Syndrome)
    • Peripheral nerve damage: distal weakness, wasting, absent ankle jerks
    • Glove-and-stocking sensory loss in diabetic type
  3. Radiculopathy (Disc Herniation - e.g., L4/L5 prolapsed disc)
    • Nerve root compression: weakness, wasting in specific myotome
    • L4 root: weak quadriceps, reduced knee jerk
    • L5 root: weak dorsiflexion of foot (foot drop)
  4. Bell's Palsy (Facial Nerve VII palsy)
    • LMN facial nerve lesion: ipsilateral complete facial weakness (forehead spared = UMN; forehead involved = LMN)
    • Absent corneal reflex, inability to close eye, drooping mouth
  5. Werdnig-Hoffmann Disease (Spinal Muscular Atrophy Type I)
    • Degeneration of anterior horn cells in infants
    • Profound flaccidity ("floppy baby"), areflexia, tongue fasciculations
  6. Carpal Tunnel Syndrome
    • Median nerve compression at the wrist
    • Thenar muscle wasting, weakness of thumb opposition, paresthesia in median distribution

Special Case: Combined UMN + LMN Lesions

Amyotrophic Lateral Sclerosis (ALS / Motor Neuron Disease) is the classic example where BOTH UMN and LMN are involved simultaneously:
  • UMN signs: spasticity, Babinski, brisk reflexes
  • LMN signs: fasciculations, wasting, weakness
  • Finding an atrophic, wasted muscle with a brisk reflex is "almost pathognomonic" of ALS

Summary Table of Examples

Lesion SiteExample DiseaseKey Signs
Cortex (UMN)Stroke, Brain tumorContralateral hemiplegia, spasticity, Babinski+
Internal Capsule (UMN)Hypertensive hemorrhageContralateral hemiplegia, face + arm + leg
Spinal Cord (UMN below lesion)MS, Cervical myelopathy, TraumaSpastic paraplegia/quadriplegia, clonus
Anterior Horn Cell (LMN)Polio, ALS (LMN), SMAFlaccid paralysis, fasciculations, severe atrophy
Nerve Root (LMN)Disc prolapse (radiculopathy)Dermatomal/myotomal weakness, reduced reflex
Peripheral Nerve (LMN)Bell's palsy, Carpal tunnelFocal muscle weakness and wasting in nerve territory

Sources: Neuroanatomy through Clinical Cases, 3rd Ed.; Frameworks for Internal Medicine; Ganong's Review of Medical Physiology, 26th Ed.


Q30. Describe the Bruce Protocol (15 Marks)


Introduction

The Bruce Protocol is the most widely used standardized treadmill exercise stress test (EST), designed by Dr. Robert A. Bruce in 1963. It is used to assess cardiovascular fitness, diagnose coronary artery disease (CAD), stratify cardiac risk, and evaluate exercise tolerance. It is an exercise electrocardiographic test (EET) performed on a motorized treadmill with simultaneous ECG, blood pressure, and heart rate monitoring.

Purpose / Indications

The Bruce Protocol is the stress modality of choice for evaluating patients of intermediate risk for CAD who are able to exercise. Specific indications include:
  1. Diagnosis of coronary artery disease (CAD) - evaluation of chest pain of uncertain etiology
  2. Risk stratification in known stable angina, post-MI, or post-revascularization
  3. Assessment of functional capacity (in METs) before surgery or rehabilitation
  4. Evaluation of exercise-induced arrhythmias
  5. Assessment of blood pressure response to exercise
  6. Monitoring treatment response (e.g., anti-anginal medications)
  7. Pre-operative cardiac risk assessment
  8. Workmen's compensation or disability evaluation
  9. Screening in selected high-risk populations

Principle

The Bruce Protocol uses a motorized treadmill with progressive increases in speed and grade (incline) every 3 minutes. Each 3-minute period is called a stage. As speed and incline increase, the cardiac workload (measured in Metabolic Equivalents - METs) and oxygen consumption (VO2) progressively rise. The heart rate, blood pressure, ECG, and symptoms are monitored continuously throughout exercise and during a recovery period.

Standard Bruce Protocol - Stages

StageSpeed (mph)Grade (%)METsO2 Consumption (mL/kg/min)
I1.710413
II2.5126.625
III3.4141034
IV4.21614.246
V5.01817+>56
  • Each stage lasts 3 minutes
  • A normal healthy individual should reach at least Stage III or IV
  • The target heart rate is 85-90% of the predicted maximum heart rate (pMHR = 220 - age)

Modified Bruce Protocol

For debilitated, elderly, or sedentary patients who cannot tolerate the abrupt start of Stage I, the Modified Bruce Protocol adds two preliminary stages (Stages 0 and 0.5) at lower workloads (1.7 mph at 0% grade, then 1.7 mph at 5% grade), each lasting 3 minutes. Modified protocols typically maintain the same speed and vary only the elevation to allow more gradual progression.

Pre-Test Preparation

  1. Patient should fast for at least 2 hours before the test
  2. Avoid alcohol, caffeine, and OTC medications the day before
  3. Wear comfortable walking/jogging shoes; underwire bras contraindicated
  4. Beta-blockers and rate-limiting calcium channel blockers should be withheld if the test is to diagnose CAD (they suppress heart rate and prevent reaching target HR)
  5. Digoxin can cause ST artifact - ideally withheld 2 weeks prior
  6. Resting 12-lead ECG is obtained before beginning
  7. Resting blood pressure is measured in standing position

Monitoring During the Test

Throughout all stages and recovery, the following are continuously recorded:
  • 12-lead ECG (especially ST segment changes)
  • Heart rate (HR)
  • Systolic and diastolic blood pressure (BP) - measured at the end of each stage
  • Symptoms - chest pain, dyspnea, fatigue, dizziness (using Borg Perceived Exertion Scale)
  • Rate-Pressure Product (RPP) = HR × SBP (index of myocardial oxygen demand; >25,000 indicates good effort)

Endpoints (Termination Criteria)

Absolute Indications to Stop the Test:

  1. Drop in systolic BP below resting standing level (especially after first 2 minutes) - suggests severe LV dysfunction
  2. Worsening anginal chest pain severe enough that the patient wants to stop
  3. CNS symptoms - dizziness, disorientation, near-syncope
  4. Signs of poor perfusion - pallor, cyanosis, severe dyspnea
  5. Serious arrhythmias - 3 or more consecutive PVCs (ventricular tachycardia), atrial arrhythmia with hemodynamic compromise
  6. Marked ECG changes: >3 mm horizontal or downsloping ST depression, or 1 mm ST elevation
  7. Technical equipment failure
  8. Maximal voluntary effort attained
  9. Patient requests to stop

Relative Indications to Stop:

  1. Worrisome ST or QRS changes (excessive junctional depression, marked axis shift)
  2. Significant fatigue, shortness of breath, wheezing, leg cramps, or claudication
  3. Worrisome appearance, especially in elderly patients
  4. Hypertensive response (SBP >250 mmHg)

Interpretation - Positive Test Criteria

The test is considered positive for ischemia if ANY of the following occur:
  1. New ST-segment depression > 1 mm (horizontal or downsloping) in 2 or more contiguous leads
  2. ST-segment elevation > 1 mm in a non-Q wave lead
  3. Hypotensive response to exercise (SBP falls during exercise)
  4. Sustained ventricular arrhythmias precipitated by exercise
  5. Exercise-induced angina

Duke Treadmill Score (DTS)

The DTS provides prognostic information for patients with chronic angina:
DTS = Minutes exercised - (5 × max ST deviation in mm) - (4 × angina score)
Angina score: 0 = none; 1 = angina present, not test-limiting; 2 = test-limiting angina
DTS ScoreAnnual MortalityRisk Category
≥ +50.25%Low risk
-10 to +41.25%Intermediate risk
< -10> 5%High risk

Contraindications to Performing the Bruce Protocol

Absolute Contraindications:

  • Acute MI within 2 days
  • Unstable angina not stabilized by medical therapy
  • Cardiac arrhythmias causing symptoms or hemodynamic compromise
  • Symptomatic severe aortic stenosis
  • Symptomatic heart failure
  • Acute pulmonary embolism, myocarditis, pericarditis, or aortic dissection

Relative Contraindications:

  • Left main coronary stenosis
  • Moderate valvular heart disease
  • Electrolyte abnormalities
  • Severe hypertension (>200/110 mmHg at rest)
  • Hypertrophic obstructive cardiomyopathy
  • High-degree AV block

When Exercise Testing is Combined with Imaging

When combined with echocardiography or nuclear perfusion imaging and the test is normal at target heart rate:
  • Risk of infarction or death from CVD is <1% annually in patients with no prior IHD history
  • For patients requiring pharmacologic stress (unable to exercise): annual risk of infarction/death is ~2% per year even with a normal study - this underscores that inability to exercise itself is a marker of increased cardiovascular risk

Limitations of the Bruce Protocol

  1. The large workload jumps between stages may cause premature test termination in elderly, sedentary, or deconditioned patients
  2. Not suitable for patients with orthopedic limitations (use bicycle ergometer or pharmacologic test instead)
  3. Extrapolation from Bruce treadmill time overestimates true exercise capacity (VO2) compared to direct measurement
  4. False positives in women (the standard Bruce protocol may be "too rigorous for many women" and precipitate excessive fatigue with premature termination - individualized protocols or pharmacologic testing may be preferred)
  5. Left bundle branch block (LBBB) or paced rhythms increase false-positive rates - pharmacologic stress preferred in these cases

Conclusion

The Bruce Protocol is a systematic, standardized exercise stress test with well-defined stages of increasing treadmill speed and grade. It allows objective assessment of cardiovascular fitness, detection of exercise-induced ischemia, and prognostic risk stratification. The Modified Bruce Protocol extends its utility to more vulnerable patient populations. Proper patient preparation, continuous monitoring, adherence to termination criteria, and correct interpretation of ECG changes are all essential to safe and accurate test performance.

Sources: Pfenninger and Fowler's Procedures for Primary Care, 3rd Ed.; The Washington Manual of Medical Therapeutics; Harrison's Principles of Internal Medicine, 22nd Ed.; Miller's Anesthesia, 10th Ed.
This is a shared conversation. Sign in to Orris to start your own chat.